Clinical Trials Directory

Trials / Completed

CompletedNCT00659763

Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome

Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome and the Prevalence of Intestinal Parasites in Patients Suspected of Irritable Bowel Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
149 (actual)
Sponsor
Zealand University Hospital · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a clinical diagnosis of irritable bowel syndrome based on patient reported symptoms and a few blood tests is safe, and to determine whether a clinical diagnosis is as good for the patient and as economical for the society as a diagnosis based on exclusion of a number of organic diseases by performing a number of blood tests, fecal analyzes and a scopic examination of bowel. The purpose of the second part of the study is to determine which intestinal parasites the patients have in their bowel and whether these parasites are the cause of the disease.

Conditions

Interventions

TypeNameDescription
OTHERExclusion diagnosisPatient fulfill ROME III criteria No Alarmsignals Blood tests: FBC,CRP, ALAT, bilirubins, bas.phosphatases, Albumine, TSH, calcium, celiac screening, lactase gene test. 3 consecutive fecal samples for worm, ovaes and parasites Sigmoidoscopy with biopsy
OTHERClinical diagnosisPatient fulfill ROME III criteria No Alarm signals Blood tests: FBC, CRP.

Timeline

Start date
2008-02-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2008-04-16
Last updated
2019-03-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00659763. Inclusion in this directory is not an endorsement.